PDF(Pubmed)
Abstract：
UNASSIGNED: The use of mobile health (mHealth, wireless communication devices, and/or software technologies) in health care delivery has increased rapidly in recent years. Their integration into disease management programs (DMPs) has tremendous potential to improve outcomes for patients with coronary artery disease (CAD), yet a more robust evaluation of the evidence is required.
UNASSIGNED: The purpose of this study was to undertake a systematic review and meta-analysis of mHealth-enabled DMPs to determine their effectiveness in reducing readmissions and mortality in patients with CAD.
UNASSIGNED: We systematically searched English language studies from January 1, 2007, to August 3, 2021, in multiple databases. Studies comparing mHealth-enabled DMPs with standard DMPs without mHealth were included if they had a minimum 30-day follow-up for at least one of all-cause or cardiovascular-related mortality, readmissions, or major adverse cardiovascular events.
UNASSIGNED: Of the 3,411 references from our search, 155 full-text studies were assessed for eligibility, and data were extracted from 18 publications. Pooled findings for all-cause readmissions (10 studies, n = 1,514) and cardiac-related readmissions (9 studies, n = 1,009) indicated that mHealth-enabled DMPs reduced all-cause (RR: 0.68; 95% CI: 0.50-0.91) and cardiac-related hospitalizations (RR: 0.55; 95% CI: 0.44-0.68) and emergency department visits (RR: 0.37; 95% CI: 0.26-0.54) compared to DMPs without mHealth. There was no significant reduction for mortality outcomes (RR: 1.72; 95% CI: 0.64-4.64) or major adverse cardiovascular events (RR: 0.68; 95% CI: 0.40-1.15).
UNASSIGNED: DMPs integrated with mHealth should be considered an effective intervention for better outcomes in patients with CAD.
UNASSIGNED: The purpose of this study was to undertake a systematic review and meta-analysis of mHealth-enabled DMPs to determine their effectiveness in reducing readmissions and mortality in patients with CAD.
UNASSIGNED: We systematically searched English language studies from January 1, 2007, to August 3, 2021, in multiple databases. Studies comparing mHealth-enabled DMPs with standard DMPs without mHealth were included if they had a minimum 30-day follow-up for at least one of all-cause or cardiovascular-related mortality, readmissions, or major adverse cardiovascular events.
UNASSIGNED: Of the 3,411 references from our search, 155 full-text studies were assessed for eligibility, and data were extracted from 18 publications. Pooled findings for all-cause readmissions (10 studies, n = 1,514) and cardiac-related readmissions (9 studies, n = 1,009) indicated that mHealth-enabled DMPs reduced all-cause (RR: 0.68; 95% CI: 0.50-0.91) and cardiac-related hospitalizations (RR: 0.55; 95% CI: 0.44-0.68) and emergency department visits (RR: 0.37; 95% CI: 0.26-0.54) compared to DMPs without mHealth. There was no significant reduction for mortality outcomes (RR: 1.72; 95% CI: 0.64-4.64) or major adverse cardiovascular events (RR: 0.68; 95% CI: 0.40-1.15).
UNASSIGNED: DMPs integrated with mHealth should be considered an effective intervention for better outcomes in patients with CAD.
摘要：
■移动医疗的使用(mHealth，无线通信设备，和/或软件技术）在医疗保健服务中的应用近年来迅速增长。将其纳入疾病管理计划（DMP）对改善冠状动脉疾病（CAD）患者的预后具有巨大潜力。然而，需要对证据进行更有力的评估。
■本研究的目的是对mHealth启用的DMPs进行系统评价和荟萃分析，以确定其在降低CAD患者再入院和死亡率方面的有效性。
■我们在多个数据库中系统地搜索了2007年1月1日至2021年8月3日的英语语言研究。如果至少对全因死亡率或心血管相关死亡率之一进行了至少30天的随访，则包括将mHealth启用的DMPs与无mHealth的标准DMPs进行比较的研究。再入院,或主要不良心血管事件。
■在我们搜索的3,411个引用中，对155项全文研究进行了资格评估，数据来自18种出版物。全因再入院的汇总结果(10项研究，n=1,514）和心脏相关的再入院（9项研究，n=1,009）表明，与没有mHealth的DMP相比，mHealth启用的DMP减少了所有原因（RR：0.68；95％CI：0.50-0.91）和心脏相关的住院（RR：0.55；95％CI：0.44-0.68）和急诊科就诊（RR：0.37；95％CI：0.26-0.54）。死亡率（RR：1.72;95％CI：0.64-4.64）或主要不良心血管事件（RR：0.68;95％CI：0.40-1.15）没有显着降低。
■与mHealth整合的DMPs应被认为是改善CAD患者预后的有效干预措施。
■本研究的目的是对mHealth启用的DMPs进行系统评价和荟萃分析，以确定其在降低CAD患者再入院和死亡率方面的有效性。
■我们在多个数据库中系统地搜索了2007年1月1日至2021年8月3日的英语语言研究。如果至少对全因死亡率或心血管相关死亡率之一进行了至少30天的随访，则包括将mHealth启用的DMPs与无mHealth的标准DMPs进行比较的研究。再入院,或主要不良心血管事件。
■在我们搜索的3,411个引用中，对155项全文研究进行了资格评估，数据来自18种出版物。全因再入院的汇总结果(10项研究，n=1,514）和心脏相关的再入院（9项研究，n=1,009）表明，与没有mHealth的DMP相比，mHealth启用的DMP减少了所有原因（RR：0.68；95％CI：0.50-0.91）和心脏相关的住院（RR：0.55；95％CI：0.44-0.68）和急诊科就诊（RR：0.37；95％CI：0.26-0.54）。死亡率（RR：1.72;95％CI：0.64-4.64）或主要不良心血管事件（RR：0.68;95％CI：0.40-1.15）没有显着降低。
■与mHealth整合的DMPs应被认为是改善CAD患者预后的有效干预措施。
